These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 23127721)
61. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Palmer SM; Robinson LJ; Wang A; Gossage JR; Bashore T; Tapson VF Chest; 1998 Jan; 113(1):237-40. PubMed ID: 9440597 [TBL] [Abstract][Full Text] [Related]
62. Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation. Della Rocca G; Coccia C; Costa MG; Pompei L; Di Marco P; Vizza CD; Venuta F; Rendina EA; Pietropaoli P; Cortesini R Transplant Proc; 2001; 33(1-2):1634-6. PubMed ID: 11267451 [No Abstract] [Full Text] [Related]
63. Acute pulmonary edema caused by epoprostenol infusion in a child with scimitar syndrome and pulmonary hypertension. von Schnakenburg C; Peuster M; Norozi K; Roebl M; Maibohm M; Wessel A; Fink C Pediatr Crit Care Med; 2003 Jan; 4(1):111-4. PubMed ID: 12656556 [TBL] [Abstract][Full Text] [Related]
64. Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin. Kesten S; Dainauskas J; McLaughlin V; Rich S Chest; 1999 Aug; 116(2):566-9. PubMed ID: 10453891 [TBL] [Abstract][Full Text] [Related]
65. Hypocalcemia after Denosumab in a Pulmonary Hypertension Patient Receiving Epoprostenol. De Muynck B; Leys M; Cuypers J; Vanderschueren D; Delcroix M; Belge C Respiration; 2018; 95(2):139-142. PubMed ID: 29485420 [TBL] [Abstract][Full Text] [Related]
66. The globalization of clinical trials in pulmonary arterial hypertension. Park MH; Rubin LJ J Heart Lung Transplant; 2010 Feb; 29(2):157-8. PubMed ID: 20113908 [No Abstract] [Full Text] [Related]
67. Comparative analysis of Micrococcus luteus isolates from blood cultures of patients with pulmonary hypertension receiving epoprostenol continuous infusion. Hirata Y; Sata M; Makiuchi Y; Morikane K; Wada A; Okabe N; Tomoike H J Infect Chemother; 2009 Dec; 15(6):424-5. PubMed ID: 20012737 [TBL] [Abstract][Full Text] [Related]
72. Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room. Bhatt AM; Stein EJ Anesthesiology; 2017 Aug; 127(2):383. PubMed ID: 28323647 [No Abstract] [Full Text] [Related]
76. Indwelling central venous catheter occlusion during chronic epoprostenol infusion. Kopeć G; Waligóra M; Stępniewski J; Podolec P J Heart Lung Transplant; 2018 Jul; 37(7):938-940. PubMed ID: 29731239 [No Abstract] [Full Text] [Related]
77. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Kerr KM; Rubin LJ Chest; 2003 Feb; 123(2):319-20. PubMed ID: 12576339 [No Abstract] [Full Text] [Related]
78. The "Flolan Rash": An Impressively Asymptomatic and Non-Inflammatory Eruption Following Long-Term Epoprostenol Therapy. Hutchison D; Juhasz M; Smith J; Lee B J Drugs Dermatol; 2022 Nov; 21(11):1249-1251. PubMed ID: 36342724 [TBL] [Abstract][Full Text] [Related]
79. Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension. Miura Y; Kataoka M; Chiba T; Inami T; Yoshino H; Satoh T Circ J; 2018 Sep; 82(10):2676-2677. PubMed ID: 30135321 [TBL] [Abstract][Full Text] [Related]